Autolus Therapeutics (AUTL) Receivables (2022 - 2025)
Historic Receivables for Autolus Therapeutics (AUTL) over the last 5 years, with Q3 2025 value amounting to $33.5 million.
- Autolus Therapeutics' Receivables rose 550869.57% to $33.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.5 million, marking a year-over-year increase of 550869.57%. This contributed to the annual value of $1.4 million for FY2024, which is 12976.0% up from last year.
- Autolus Therapeutics' Receivables amounted to $33.5 million in Q3 2025, which was up 550869.57% from $27.3 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Receivables registered a high of $33.5 million during Q3 2025, and its lowest value of $384000.0 during Q4 2021.
- Moreover, its 5-year median value for Receivables was $1.4 million (2024), whereas its average is $7.7 million.
- As far as peak fluctuations go, Autolus Therapeutics' Receivables crashed by 7628.87% in 2024, and later soared by 550869.57% in 2025.
- Autolus Therapeutics' Receivables (Quarter) stood at $384000.0 in 2021, then surged by 305.21% to $1.6 million in 2022, then plummeted by 59.83% to $625000.0 in 2023, then soared by 129.76% to $1.4 million in 2024, then soared by 2235.65% to $33.5 million in 2025.
- Its last three reported values are $33.5 million in Q3 2025, $27.3 million for Q2 2025, and $14.7 million during Q1 2025.